Walleye Capital’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-10,915
Closed -$94K – 2764
2021
Q4
$94K Buy
+10,915
New +$69.4K ﹤0.01% 1701
2021
Q3
– Sell
-30,878
Closed -$205K – 1910
2021
Q2
$205K Buy
+30,878
New +$195K 0.01% 1060

Other funds holding LHDX

Walleye Capital's LHDX Position: Q1 2022 in Review

Walleye Capital sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 10,915 shares — an estimated $94K sold.

Walleye Capital first reported a position in LHDX in Q2 2021 and held it in 2 quarters. The position peaked at $205K in Q2 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

  • Walleye Capital reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Walleye Capital sold 10,915 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $94K.
  • Walleye Capital first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Walleye Capital's Lucira Health, Inc. Common Stock position peaked at $205K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.